LEADING PHARMA — Ofloxacin Importer Profile
Pharmaceutical Importer · #16 buyer for Ofloxacin · $3.9M import value · 107 shipments · UNITED STATES · DGFT Verified
LEADING PHARMA is the #16 importer of Ofloxacin from India with $3.9M in import value and 107 verified shipments. LEADING PHARMA holds a 0.7% market share in Ofloxacin imports based in UNITED STATES. The company sources from 2 verified suppliers across 45 formulations shipped to 1 country. Overall, LEADING PHARMA imports 2 pharmaceutical products worth $5.7M across 2 therapeutic categories.
LEADING PHARMA — Ofloxacin Import Profile: Suppliers, Formulations & Sources
Who Actually Supplies Ofloxacin to LEADING PHARMA?
Verified from 107 customs shipment records
| Supplier | Value | Shipments | % Share |
|---|---|---|---|
| FDC LIMITED | $3.1M | 79 | 80.0% |
| CAPLIN STERILES LIMITED | $773.6K | 28 | 20.0% |
LEADING PHARMA sources Ofloxacin from 2 verified Indian suppliers based on 107 customs records. The primary supplier is FDC LIMITED accounting for 80.0% of imports.
How Does LEADING PHARMA Compare to Nearest Ofloxacin Importers?
Buyers ranked immediately above and below #16 by import value
| # | Buyer | Country | Import Value | Shipments | Avg/Shipment |
|---|---|---|---|---|---|
| 7 | LLC SENTISS RUS | RUSSIA | $3.1M | 62 | $50.0K |
| 13 | RISING PHARMA HOLDINGS, INC. | UNITED STATES | $3.0M | 61 | $50.0K |
| 16 | LEADING PHARMA ★ | UNITED STATES | $2.1M | 43 | $50.0K |
| 17 | FIDSON HEALTHCARE PLC | NIGERIA | $1.6M | 33 | $50.0K |
| 15 | AO RANBAXY | RUSSIA | $1.4M | 28 | $50.0K |
LEADING PHARMA ranks #16 among 3,093 Ofloxacin importers from India. Average shipment value of $50.0K compared to the market average of $7.2K. The closest competitors by value are LLC SENTISS RUS and RISING PHARMA HOLDINGS, INC..
Where Does LEADING PHARMA Import Ofloxacin To?
Destination countries from 107 verified shipments
| Country | Value | Shipments | Share |
|---|---|---|---|
| UNITED STATES | $3.9M | 107 | 100.0% |
LEADING PHARMA imports Ofloxacin to 1 country. The primary destination is UNITED STATES receiving 100.0% of shipments worth $3.9M.
What Ofloxacin Formulations Does LEADING PHARMA Import?
| Formulation | Value | Shipments |
|---|---|---|
| CIPROFLOXACIN OPHTHALMIC SOLUTION USP 0. | $1.1M | 23 |
| CIPROFLOXACIN OPHTHALMIC SOLUTION USP 0.3% 5 MLVLS | $393.9K | 9 |
| CIPROFLOXACIN OPHTHALMIC SOLUTION USP 0.3% 5ML (CIPROFLOXACIN OPHTHALMIC SOLUTION USP 0.3% W/V) | $300.0K | 6 |
| CIPROFLOXACIN OPHTHALMIC SOLUTION USP 0 3 2 5ML CIPROFLOXACIN OPHTHALMIC SOLUTION USP 0 3 W V | $172.2K | 4 |
| CIPROFLOXACIN OPHTHALMIC SOLUTION USP 0.3% 5 ML BATCH NO.084A067 MFG DT.01/2024EXP DT.12/2025VLS | $133.6K | 3 |
| PHARMACEUTICAL FORMULATIONS - OFLOXACINOTIC SOLUTION 0.3%, 15MG/5ML (3MG/ML) -5ML DROPPER BOTTLE | $104.3K | 3 |
| CIPROFLOXACIN OPHTHALMIC SOLUTION USP 0.3% 5 ML BATCH NO.084A032 MFG DT.01/2024EXP DT.12/2025VLS | $102.3K | 3 |
| CIPROFLOXACIN OPHTHALMIC SOLUTION USP 0.3% 5ML (CIPROFLOXACIN OPHTHALMIC SOLUTION USP 0.3% W/V)VLS | $101.3K | 3 |
| CIPROFLOXACIN OPHTHALMIC SOLUTION USP 0.3% 5 ML BATCH NO.083L111 MFG DT.12/2023EXP DT.11/2025VLS | $100.9K | 3 |
| CIPROFLOXACIN OPHTHALMIC SOLUTION USP 0 3 5ML CIPROFLOXACIN OPHTHALMIC SOLUTION USP 0 3 W V | $100.0K | 2 |
LEADING PHARMA imports 45 distinct Ofloxacin formulations from India. The top formulation is CIPROFLOXACIN OPHTHALMIC SOLUTION USP 0. with 23 shipments worth $1.1M.
Regulatory Requirements: Importing Ofloxacin into United States
What LEADING PHARMA and other importers must comply with to import Ofloxacin from India
Regulatory Authority
U.S. Food and Drug Administration (FDA)
Approval Process for Generic Ofloxacin
Abbreviated New Drug Application (ANDA) for generic drugs, requiring bioequivalence studies and compliance with 21 CFR. Indian manufacturing sites must pass FDA pre-approval inspection.
Typical timeline: 10–18 months for ANDA approval
GMP Requirements
FDA cGMP compliance (21 CFR 210/211); facility inspection by FDA prior to approval
Import Licence & Documentation
Drug Listing with FDA; Import Alert screening; Customs entry via FDA PREDICT system
Labeling & Packaging
US-specific labeling per 21 CFR 201 including NDC number, lot, expiry, dosage in English
Note: Subject to FDA Import Alerts and Automatic Detention if facility has open Form 483 observations.
Regulatory information is provided for general reference based on publicly available FDA guidelines for pharmaceutical imports. Requirements may vary by specific drug formulation, dosage form, and therapeutic classification. Importers should consult directly with FDA or qualified regulatory affairs professionals for case-specific guidance.
Who Are the Top Buyers of Ofloxacin from India and How Much Does LEADING PHARMA Import?
India exported $22.2M worth of Ofloxacin through 15,000 shipments from 1094 suppliers to 180 countries, serving 3,093 buyers globally. LEADING PHARMA imports $3.9M of this total, accounting for 0.7% of India's Ofloxacin exports with 107 shipments from UNITED STATES. This is verified from 107 customs shipment records covering 45 distinct formulations.
What Is the Average Order Value for LEADING PHARMA's Ofloxacin Imports?
LEADING PHARMA's average Ofloxacin order value is $36.2K per consignment, based on 107 shipments totaling $3.9M. LEADING PHARMA is based in UNITED STATES and ranks #16 among all Ofloxacin importers from India by value. The company sources from 2 verified suppliers in India.
Who Supplies Ofloxacin to LEADING PHARMA?
LEADING PHARMA sources Ofloxacin from 2 verified Indian suppliers: FDC LIMITED ($3.1M, 80.0%), CAPLIN STERILES LIMITED ($773.6K, 20.0%). This is based on 107 customs records.
How Does LEADING PHARMA Compare to Other Ofloxacin Importers?
LEADING PHARMA ranks #16 among 3,093 Ofloxacin importers from India with a 0.7% market share. The top 3 importers are LIFESTAR PHARMA LLC ($5.8M), LLC SENTISS RUS ($3.1M), RISING PHARMA HOLDINGS, INC. ($3.0M). LEADING PHARMA processed 107 shipments from UNITED STATES.
About LEADING PHARMA
LEADING PHARMA imports 2 products worth $5.7M. Beyond Ofloxacin, top products include Ciprofloxacin. View the complete LEADING PHARMA profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Ofloxacin — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- European Medicines Agency
- WHO Essential Medicines
- Invest India — Pharma Sector
- India Trade Statistics (DGFT)
Verify import regulations and drug registration requirements with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Ofloxacin shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature and HS code classification.
- 2.Buyer Identification: LEADING PHARMA matched across shipments using first-3-word normalization of the consignee field, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort buyer rankings.
- 4.Market Share: Calculated as LEADING PHARMA's capped import value divided by total capped export value for Ofloxacin across all Indian exporters.
- 5.Verified Records: This page is backed by 107 individual customs records matching LEADING PHARMA importing Ofloxacin, covering 45 formulations from 2 verified suppliers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 180+ countries, 3,093+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Ofloxacin Import Data for LEADING PHARMA
Access order-level details, pricing data, supplier connections, and competitive analysis for LEADING PHARMA's Ofloxacin imports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
LEADING PHARMA
Full Company Profile →
2 products · $5.7M total trade · 2 categories
LEADING PHARMA × Ofloxacin
Verified from customs records
Company Overview
Top Products by LEADING PHARMA
Related Analysis
Need Detailed Import Data?
Access shipment-level records, supplier contacts, and formulation details for LEADING PHARMA.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Ofloxacin. For current order-level data, contact TransData Nexus.